Banner
Banner
•••
Horizon 2020 (2014 - 2020)

Biosafety assays for the diagnosis and prediction of drug-related complement pathology - Biosafety

Last update: Aug 25, 2020 Last update: 25 Aug, 2020

Details

Locations: Germany, Hungary, Italy, Netherlands
Start Date: Sep 1, 2020
End Date: Aug 31, 2023
Value: € 900 000
Sectors: Health, Research Health, Research
Categories: Grants
Date posted: Aug 25, 2020

Associated funding

Associated experts

Description

Call for proposal: H2020-WIDESPREAD-2020-5
Funding Scheme: CSA - Coordination and support action
Grant agreement ID: 952520

Objective: The objective of this Twinning project is to significantly strengthen the research in SEMMELWEIS EGYETEM in the smart specialization area of Hungary “bio- medicine, medical technologies, and biotechnologies” with application to immune- and biosafety assays through building an up-rising connections with internationally leading research institutions, which represent centers of excellence in the design, testing and clinical applications of a wide class of Immunotherapeutics, with focus on infusion reactions (IRs). IRs are complex, immune-mediated side effects, also known as hypersensitivity reactions (HSRs), that can occur upon intravenous infusion of pharmaceuticals, leading to severe and sometimes life-threatening conditions in patients. Regulatory guidance on the assessment of infusion hypersensitivity has been published recently for the case of generic liposome production. Hemocompatibility (blood safety) testing for medical devices is requested by EMA and FDA since many years. However, regarding the potential of new pharmaceuticals causing allergies remains a significant challenge for the industry during nonclinical development as no established safety biomarker nor meaningful, validated animal models are available up to date and this will be addressed in the BIOSAFETY project.

Reference — Biosafety assays for the diagnosis and prediction of drug-related complement pathology - Biosafety — for Germany, Hungary, Italy, Netherlands presented by Horizon 2020 (2014 - 2020) (grants), budget is € 900 000, in Health, Research sectors. Reference — Biosafety assays for the diagnosis and prediction of drug-related complement pathology - Biosafety — for Germany, Hungary, Italy, Netherlands presented by Horizon 2020 (2014 - 2020) (grants), budget is € 900 000, in Health, Research sectors. Reference — Biosafety assays for the diagnosis and prediction of drug-related complement pathology - Biosafety — for Germany, Hungary, Italy, ...
Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.